V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004232 | 330002083 | null | 51.7 | Curative (C) | null | 2017-02-28 | OST Euramos 1 Closed Trial - AP | null | null | 330016757 | MAP |
| 330004233 | 330002083 | 1.68 | 66.4 | Neo-adjuvant (N) | 2014-09-27 | 2014-10-08 | Dox + HD Mtx (post PAM) | N | N | 330016757 | DOXORUBICIN + HD MTX |
| 330004234 | 330002083 | 1.81 | 74.1 | Not known (9) | 2014-12-31 | 2015-01-10 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 330016757 | CARBO + FLUOROURACIL |
| 330004235 | 330002083 | 1.66 | 49 | Palliative (P) | 2018-01-05 | 2018-01-06 | CARBO + FLUOROURACIL | 02 | N | 330016757 | CARBO + FLUOROURACIL |
| 330004236 | 330002083 | 1.68 | 88 | Palliative (P) | 2014-02-01 | 2014-02-05 | CAP | N | N | 330016757 | CAP |
| 330004237 | 330002083 | null | 84.1 | Neo-adjuvant (N) | 2015-03-11 | 2015-03-23 | CISPLATIN + GEMCITABINE | N | N | 330016757 | CISPLATIN + GEMCITABINE |
| 330004238 | 330002084 | null | 17.6 | Palliative (P) | 2014-03-27 | 2014-04-07 | Dox + HD Mtx (post PAM) | 2 | N | 330016794 | DOXORUBICIN + HD MTX |
| 330004239 | 330002085 | 1.6 | 85 | Palliative (P) | 2014-09-11 | 2014-10-08 | GemCarbo Days 1+8 | N | N | 330016800 | GEMCARBO |
| 330004240 | 330002086 | 0 | 57 | Neo-adjuvant (N) | 2014-03-15 | 2014-04-02 | EW EuroEwing 99 : VIDE | N | N | 330016809 | EURO-EWING |
| 330004241 | 330002086 | 1.76 | 54 | Palliative (P) | null | 2016-08-26 | Cyclophosphamide + Dex + Rituximab | null | null | 330016809 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004242 | 330002087 | null | null | Curative (C) | 2013-10-26 | 2013-12-29 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330016821 | CARBO + FLUOROURACIL |
| 330004243 | 330007141 | 1.7 | 98 | Curative (C) | 2017-06-25 | 2017-06-26 | DA 3 + 10 | 02 | N | 330016822 | DA |
| 330004244 | 330002088 | 1.8 | 92.2 | Palliative (P) | 2013-11-11 | 2013-11-12 | CVP R | 02 | N | 330016828 | CVP R |
| 330004245 | 330002088 | 0 | 72.9 | Curative (C) | 2016-01-29 | 2016-02-02 | Dox + HD Mtx (post PAM) | 02 | N | 330016828 | DOXORUBICIN + HD MTX |
| 330004247 | 330007143 | 0 | 76.7 | Curative (C) | null | 2013-12-26 | Cetuximab 7 day (Cycle 1) | N | Y | 330016868 | CETUXIMAB |
| 330004248 | 330007143 | null | null | Not known (9) | 2018-01-13 | 2018-01-17 | CVP R | N | N | 330016868 | CVP R |
| 330004249 | 330007143 | 1.69 | 78 | Neo-adjuvant (N) | 2014-03-22 | 2014-04-01 | EW EuroEwing 2012 Arm A VIDE | Y | N | 330016868 | EURO-EWING |
| 330004250 | 330007143 | 1.78 | 88 | null | 2017-01-25 | 2017-01-30 | Cetuximab + Radiotherapy Load | null | N | 330016868 | CETUXIMAB + RT |
| 330004251 | 330007143 | 1.66 | 50.4 | Palliative (P) | 2013-04-12 | 2013-04-26 | CISPLATIN + ETOPOSIDE | N | N | 330016868 | CISPLATIN + ETOPOSIDE |
| 330004252 | 330007143 | null | null | Palliative (P) | 2017-02-27 | 2017-02-27 | GemCarbo Days 1+8 | N | N | 330016868 | GEMCARBO |
| 330004253 | 330002090 | 1.54 | 63.5 | null | null | 2015-09-25 | CETUXIMAB + RT | N | Y | 330016924 | CETUXIMAB + RT |
| 330004254 | 330002090 | 1.8 | 80 | Palliative (P) | 2015-02-02 | 2015-02-02 | GemCarbo Days 1+8 | 2 | null | 330016924 | GEMCARBO |
| 330004255 | 330002091 | 1.75 | 71.7 | Adjuvant (A) | 2014-10-21 | 2014-10-21 | CVP R | Y | N | 330016929 | CVP R |
| 330004256 | 330002092 | 1.7 | 104.8 | Palliative (P) | 2013-05-22 | 2013-06-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330016939 | CISPLATIN + GEMCITABINE |
| 330004257 | 330002092 | 1.71 | 52 | Disease modification (D) | 2013-03-25 | 2013-04-22 | CVP R | N | N | 330016939 | CVP R |
| 330004258 | 330002093 | 1.74 | 63.6 | Palliative (P) | 2015-09-03 | 2015-09-17 | CISPLATIN + GEMCITABINE | N | N | 330016958 | CISPLATIN + GEMCITABINE |
| 330004259 | 330002094 | 1.58 | 53 | Palliative (P) | 2013-08-31 | 2013-09-07 | Cyclophosphamide + Dex + Rituximab | Y | N | 330016960 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004260 | 330002095 | 1.73 | 81.9 | Disease modification (D) | 2013-11-30 | 2013-12-01 | CVP R | N | N | 330016961 | CVP R |
| 330004261 | 330002096 | 1.7 | 81 | Palliative (P) | 2016-08-16 | 2016-09-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330016967 | CISPLATIN + GEMCITABINE |
| 330004262 | 330007146 | 1.73 | 60 | Palliative (P) | 2016-03-22 | 2016-03-26 | Cisplatin + Etoposide (3 day) | 2 | N | 330016969 | CISPLATIN + ETOPOSIDE |
| 330004263 | 330007146 | 1.82 | 78 | Adjuvant (A) | 2013-02-06 | 2013-02-06 | OST Euramos 1 Closed Trial - AP | N | N | 330016969 | MAP |
| 330004264 | 330007146 | null | null | Curative (C) | 2016-07-15 | 2016-07-21 | EURO-EWING | N | N | 330016969 | EURO-EWING |
| 330004265 | 330007146 | 1.8 | 78.9 | Disease modification (D) | 2016-05-02 | 2016-05-02 | CVP R | N | N | 330016969 | CVP R |
| 330004266 | 330007146 | 1.76 | 91 | Curative (C) | 2013-10-18 | 2013-10-24 | CETUXIMAB | 2 | Y | 330016969 | CETUXIMAB |
| 330004267 | 330002097 | 1.76 | 86 | Neo-adjuvant (N) | 2017-08-30 | 2017-09-15 | GemCarbo Days 1+8 | N | N | 330016987 | GEMCARBO |
| 330004268 | 330002097 | 1.85 | 73 | Adjuvant (A) | 2015-10-15 | 2015-10-18 | Cetuximab + Radiotherapy Load | N | Y | 330016987 | CETUXIMAB + RT |
| 330004269 | 330009873 | 1.56 | 54.4 | Curative (C) | 2016-03-18 | 2016-03-19 | CVP R | null | null | 330016989 | CVP R |
| 330004270 | 330002098 | 1.63 | 58.2 | Palliative (P) | 2014-02-14 | 2014-02-19 | GemCarbo Days 1+8 | 02 | N | 330016990 | GEMCARBO |
| 330004271 | 330002098 | 1.58 | 43 | null | 2014-10-07 | 2014-10-14 | GemCarbo Days 1+8 | N | N | 330016990 | GEMCARBO |
| 330004272 | 330002098 | 1.63 | null | Palliative (P) | 2013-05-17 | 2013-05-24 | GemCarbo Days 1+8 | N | N | 330016990 | GEMCARBO |
| 330004273 | 330002098 | 1.73 | 65.8 | Neo-adjuvant (N) | null | 2014-07-07 | Dox + HD Mtx (post PAM) | N | N | 330016990 | DOXORUBICIN + HD MTX |
| 330004274 | 330002098 | 1.6 | 38.9 | Neo-adjuvant (N) | 2016-01-20 | 2016-01-28 | OST Euramos 1 Closed Trial - AP | Y | N | 330016990 | MAP |
| 330004275 | 330002098 | 1.73 | 49.4 | Not known (9) | 2014-01-09 | 2014-01-21 | CVP R | 02 | N | 330016990 | CVP R |
| 330004276 | 330002098 | 1.67 | 70.9 | Curative (C) | 2013-06-05 | 2013-06-09 | CETUXIMAB | 2 | null | 330016990 | CETUXIMAB |
| 330004277 | 330013128 | 1.6 | 46.8 | Palliative (P) | 2015-12-26 | 2015-12-27 | Cyclophosphamide + Dex + Rituximab | 02 | N | 330017020 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330004278 | 330013221 | 1.65 | 95.4 | Curative (C) | 2016-02-23 | 2016-03-08 | CETUXIMAB | N | Y | 330017030 | CETUXIMAB |
| 330004279 | 330013221 | 1.73 | 47.9 | Palliative (P) | 2017-12-17 | 2017-12-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330017030 | CISPLATIN + GEMCITABINE |
| 330004280 | 330013221 | 0 | 69.6 | Neo-adjuvant (N) | 2013-05-16 | 2013-05-16 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330017030 | EURO-EWING |
| 330004281 | 330013221 | 1.8 | 46.6 | Curative (C) | 2013-07-17 | 2013-08-08 | Cetuximab + Radiotherapy Load | N | Y | 330017030 | CETUXIMAB + RT |
| 330004282 | 330002099 | 1.81 | 76.3 | Curative (C) | 2014-01-08 | 2014-01-17 | CETUXIMAB + RT | N | Y | 330017048 | CETUXIMAB + RT |